Celiac Disease Foundation (CDF), the nation’s leading voluntary health organization for celiac disease, announces the appointment of five new members to its Board of Directors for the 2015-2017 term. Joining the Board of Directors are: Deidre Berman, Tina Bingham, Bradley Herrema, Michael Karp, M.D., and Robbin Wilson.

“Our five new Directors bring talent, expert knowledge, and passion to the Board, and we are grateful to have their support of the Foundation,” said Marc Riches, CDF Board Chair. “The full Board looks forward to working together to drive diagnosis, treatment, and a cure for this woefully underdiagnosed genetic autoimmune disease.”

The newly elected Board Members are:

Deidre Berman, whose experience in the evolving healthcare delivery system has been multi-faceted, including a fellowship at the Henry Ford Hospital in Detroit and Strategic Planning at Kaiser Permanente and the Permanente Medical Group. For the last 15 years, Deidre has held various positions at Anthem Blue Cross (formerly Blue Cross of CA) in their Legislative/Public Policy department, Operations Management, and now as a Director of Change Management over the Large Group Accounts segment, working with both internal and external stakeholders. This business segment represents all employer customers within California that provide healthcare benefits to 50 or more employees. It includes nearly 4,000 employer groups covering over three million people, representing approximately $15 billion in annual insured and self-insured healthcare benefit payments.

Tina Bingham, who is a partner in the legal and business consulting firm, Kaleo Legal, in Virginia Beach, Virginia. Her practice focuses on corporate and securities law, public and private capital raising, corporate governance, and compliance. Tina has broad experience advising public and private company clients on a wide range of regulatory and transactional matters, and advises boards of directors, executive management teams, and entrepreneurs on business strategy, transactional planning, financing options, and investor relations.

Bradley Herrema, who is a Shareholder in Brownstein Hyatt Farber Schreck’s Los Angeles office, and a member of the Water & Public Lands and Public Agency Groups. His practice includes a broad range of water issues in the Southwest, including strategic water supply planning, water rights permitting and regulatory compliance, adjudications of groundwater rights, water utility concerns, Indian water rights, and environmental matters affecting water use, including CEQA compliance and water quality issues, including those arising under the federal Clean Water Act and California Porter-Cologne Water Quality Control Act. Brad is a Trustee for the William Sansum Diabetes Center, and a Director for the Groundwater Resources Association of California, and serves as a member of the Executive Committee for each.

Michael Karp, M.D., who graduated from the University of Southern California School of Medicine (since renamed the Keck School of Medicine). He completed training in Internal Medicine at USC, was Chief Resident of the training program, then joined the faculty of USC in July 2013. As teaching faculty, his role over the years has included supervision of medical students and residents during their training. This supervision occurs as an Attending on the General Medicine inpatient wards at the LAC+USC Medical Center, Keck Hospital of USC, and in the outpatient clinics. His current role is that of Chief of the division of Geriatrics, Hospital, Palliative Care, and General Internal Medicine within the Department of Medicine at USC.

Robbin Wilson, who has over 30 years of experience in leading a diverse portfolio of fundraising programs in nonprofit, political, and charitable arenas. She brings experience from both sides of the aisle – nonprofit and agency. Robbin is a proven leader with an entrepreneurial spirit best known for creating platforms that are unique to each organization and break-out programs that generate incremental net revenue. Robbin serves as a fundraising subject matter expert and provides strategic oversight for omni-channel program development and integration across all verticals – advocacy, public policy, publications, and regionally based charitable programs.

To view the full biographies of the Celiac Disease Foundation Board of Directors, visit https://celiac.org/about-cdf/board-of-directors/

About Celiac Disease Foundation

Celiac Disease Foundation (CDF) drives diagnosis and treatment of celiac disease, one of the world’s most common and least diagnosed genetic autoimmune diseases. A non-profit, public benefit corporation established in 1990, CDF leads the fight to improve the quality of life for all people affected by gluten-related disorders through a comprehensive program of education, advocacy, and research initiatives. For more information about CDF, visit celiac.org or call (818) 716-1513.